DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Boehringer-Ingelheim-Pharmaceuticals.
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial.
http://www.clinicaltrials.gov/ct2/show/study/NCT00808067
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.